BSEKobo Biotech Ltd-$HighNeutral
Announced Thu, 30 Oct · 19:54 IST

Outcome of the 10th CoC Meeting held on 04-06-2025

Nclt Insolvency AdmittedRegulatory & Legal View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kobo Biotech Limited, currently under Corporate Insolvency Resolution Process (CIRP), held its 10th meeting of the Committee of Creditors on June 4, 2025 in Mumbai. The CoC approved (with 99.12% voting share) the inclusion of a GST claim of Rs. 14,20,529 from the State Tax Officer, Maharashtra as an operational creditor (Government) in the list of creditors. The Resolution Professional was authorised to file an application before NCLT for inclusion of the claim and condonation of delay, with legal fees of Rs. 30,000 plus Rs. 5,000 towards out-of-pocket expenses treated as CIRP cost. The company was admitted into insolvency by the NCLT Hyderabad via order dated 17.01.2025 in C.P.(IB) 277/7/HDB/2023. Namrata Randeri continues to serve as the Resolution Professional.

Likely market impact

Routine procedural update during ongoing insolvency; the addition of a small government claim (Rs. 14.2 lakh) slightly increases the creditor pool but is unlikely to materially affect the resolution timeline. Shareholders remain at risk as equity typically gets significantly diluted or written off in CIRP outcomes.